Clinical Study

A Phase I Open-Label Study To Evaluate The Effect Of Multiple Doses Of Azd1775 On The Pharmacokinetics Of Substrates For Cyp3a, Cyp2c19, Cyp1a2 And To

Posted Date: May 15, 2019

  • Investigator: Trisha Wise-Draper
  • Type of Study: Drug

AstraZeneca D6014C00006


To Be Eligible To Participate In This Study, Patients Must Have Advanced Solid Cancer For Which Ther


Cancer, D6014c00006, Phase I, Solid Tumor

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.